Atlas Trials

A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)

Clinical trial NCT01602588 · COMPLETED

Trial details

NCT number
NCT01602588
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2013-05-01
Primary completion
2016-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.